The SENTINL-1 Study: Evaluating Patient-Reported Outcomes of AI-Inferred Lung Cancer Risk
Clinical trial NCT07458425 · RECRUITING
Trial details
- NCT number
- NCT07458425
- Sponsor
- University of Illinois at Chicago
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-11
- Primary completion
- 2027-01-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.